The Ocean 14 Capital Fund has invested in WellFish Tech, a rapid fish health assessment early-state business for the aquaculture industry.

Spun out of the University of the West of Scotland in 2021, WellFish Tech is pioneering aquaculture-diagnostics that use blood biomarkers and artificial intelligence to determine the health status of fish, enabling fish farmers to monitor and improve the health and welfare of their fish stocks to optimize production.

“We are delighted to have invested in Wellfish and be part of the aquaculture diagnostics market that is valued at £3 billion and growing,” said Francisco Saraiva Gomes, founding partner and chief investment officer at Ocean 14 Capital. “The sustainability of aquaculture and blue foods requires precision and rapid diagnostics. Wellfish' solution has the potential to become one of the de facto standards of the industry.”